International stocks trading in New York closed mixed on Monday.
The Bank of New York index of American depositary receipts rose
0.11% to 156.80. The European index increased 0.10% to 156, the
Asian index edged up 0.34% to 150.29, the Latin American index fell
0.41% to 289.59 and the emerging markets index increased 0.07% to
290.46. Among the companies with shares that actively traded were
Philips NV (PHG, PHIA.AE ) and America Movil SAB (AMOV,
AMX.MX).
Philips NV is spinning off its lighting components business in
the latest stage of the once-diversified Dutch electronics group's
plan to focus on a handful of higher-margin activities. Philips
said it would seek outside investors for its Lumileds Lighting unit
which it will combine with its automotive-lighting business. The
businesses that will be separated primarily manufacture LED
components used in products ranging from televisions and smart
phones to traffic lights. Shares rose 4.2% to $31.76.
America Movil shares continued to rise Monday on the decision by
Mexican telecommunications tycoon Carlos Slim Friday to buy back
the 8.3% stake in the wireless giant that longtime investor AT&
Inc. (T) is planning to sell. America Movil shares rose 1.6% to
$20.80.
Budget Irish airline Ryanair Holdings PLC (RYAAY, RYA.LN,
RYA.DB) said Monday it has appointed Neil Sorahan chief financial
officer starting Oct. 1. Mr. Sorahan, currently finance director,
will succeed Howard Millar, the airline's deputy chief executive
and chief financial officer. Mr. Millar plans to step down in
December, after 23 years of service, to pursue other opportunities,
the company said. Shares rose 0.49% to $55.80.
GlaxoSmithKline PLC (GSK, GSK.LN) and Theravance Inc. (THRX)
submitted a supplemental new drug application to the U.S. Food and
Drug Administration for an asthma treatment for patients aged 12
years and older. The British pharmaceutical company said the
application is for two different doses of Breo Ellipta, a
combination of fluticasone furoate and vilanterol, as a once-daily
treatment for asthma. Glaxo shares fell 0.56% to $53.48.
Write to Tess Stynes at tess.stynes@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires